Genopole, France’s leading biocluster for biotechnologies and research in genomics and genetics, unites innovative high-tech life sciences companies, public and private research and higher education facilities at a single site in Evry/Corbeil-Essonnes, just south of Paris.  Genopole is a pioneer in France.

Founded in 1998, Genopole can provide a 20 years experience of knowledge and expertise in Life sciences and more particularly in genomics biotherapies, synthetic biology and entrepreneurship.

Their innovation and business ecosystem counts ore than 2300 staff members wich are employed by 87 companies, 17 public research labs, and 28 cutting-edge shared access technology platforms and facilities for R&D.

It is a mature and fertile biotech ecosystem with innovative companies and over 190 startups which have been accredited by Genopole over the last two decades, and have been assisted through customised specialised R&D and business support services.  During that period, over €649 million have been raised by genopole's portfolio companies, and seven companies have been already listed on public markets.

An integrated cluster organisation to promote R&D, entrepreneurship and economic growth and particularly to support SMEs as well as entrepreneurs and foudners-to-be in the field of biotechnology with a dedicated staff providing access to  the SHAKER (incubator) and the BOOSTER (accelerator) programmes.

Genopole also develops prospecting actions and support for implantations of mature and high-growth business on the biocluster.

Their panel of services also include :

• accelerating biotech innovation & bioentrepreneurship
• attracting biotech SMEs and international biotech companies
• strengthening R&D potential and attracting talents
• answering to real estate needs

Genopole is also a dynamic and intense cluster life with scientific and industrial evenst and networking activities with international, European, national and regional bioclusters, technology centres and other scaling-up support organisations.